RxDoctor Payments DataLook up a doctor →

Chitharanjan Duvoor

Endocrinology, Diabetes & Metabolism · Jonesboro, ARNPI 1609131234

Payments from drug & device makers

$75,735in general payments, 2019–2025

Across 1,350 payments — averaging $56.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$25K
  • Dexcom, Inc.$24K
  • Medtronic$3K
  • Bayer$2K
  • Amgen$2K
  • AstraZeneca$2K
  • plus $17K from 53 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Abbott95$24,663
Dexcom, Inc.85$24,227
Medtronic(2 entities)67$3,361
Bayer60$2,276
Amgen(2 entities)140$2,192
AstraZeneca(2 entities)86$2,084
GE HealthCare9$1,965
Novo Nordisk111$1,885
Lilly USA, LLC98$1,715
Corcept Therapeutics56$1,569
Sanofi-aventis U.S. LLC81$1,061
Radius Health, Inc.38$922
Boehringer Ingelheim44$755
Insulet Corporation39$703
Novartis43$512
Xeris Pharmaceuticals, Inc.29$501
Otsuka America Pharmaceutical, Inc.26$462
Vifor Pharma, Inc.30$457
Johnson & Johnson28$351
OPKO Pharmaceuticals, LLC17$333
GSK18$319
Sequel Med Tech, LLC15$281
Fresenius USA Marketing, Inc.15$270
Esperion Therapeutics, Inc.8$241
Cequr Corporation3$237
Merck16$224
Tandem Diabetes Care, Inc.10$207
Kyowa Kirin, Inc.2$200
Daiichi Sankyo Inc.11$189
Travere Therapeutics, Inc.8$161
BETA Bionics, Inc.2$157
Nevro Corp.2$119
Madrigal Pharmaceuticals3$108
Mallinckrodt Hospital Products Inc.5$107
Globus Medical4$98
Averitas Pharma Inc.3$78
Shire North American Group Inc5$73
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$71
Amarin Pharma, Inc.4$58
Neurocrine Biosciences, Inc.2$48
Ionis Pharmaceuticals, Inc.2$46
Pfizer2$43
Sun Pharmaceutical Industries Inc.2$38
Nuwellis, Inc.2$38
Biohaven Pharmaceuticals, Inc.2$35
Takeda Pharmaceuticals U.S.A., Inc.2$34
Nestle Healthcare Nutrition Inc.2$33
AbbVie2$31
Teva Pharmaceuticals USA, Inc.2$29
Sanofi1$22
Aurinia Pharma U.S., Inc.1$20
Strongbridge US Inc.1$18
Jazz Pharmaceuticals Inc.1$17
Chiesi USA, Inc.1$17
Alvogen Inc1$17
Regeneron Healthcare Solutions, Inc.1$17
BD1$17
Rhythm Pharmaceuticals, Inc.1$14
Astellas Pharma US Inc1$12

How this compares

$75,735 in reported general payments places this provider in the 80th percentile of 43 endocrinology, diabetes & metabolism providers in Arkansas.

See all endocrinology, diabetes & metabolism providers in Arkansas →

Medicare billing

Part B allowed, 2024
$215,695
Medicare patients
1,171
Services billed
3,087

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Jonesboro

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →